2 independently sourced, verified news trends involving Roche.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jul 2, 2026 through Jul 16, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Emerging Alzheimer’s drug candidates are generating global attention as researchers and health advocates evaluate their potential to stop the disease.
Roche's drug candidate divarasib outperformed rival therapies in a Phase 3 trial for KRAS-driven lung cancer.